Choline as precursor of phosphatidylcholine, a major constituent of cell membranes, was negative correlated with PL ( R = 0.26, P 5 mm had higher concentration of l-carnitine, choline, betaine and TML compared to patients with CAL 5 mm (Fig
Event Phase 2 Rate (12 mg group) Phase 2 Rate (Placebo) Nausea 45.8% 11.6% Diarrhea 33.3% 9.3% Vomiting 22.2% 2.3% Constipation 16.7% 7.0% Decreased appetite 22.2% 2.3% The nausea incidence at the highest dose a nausea percentage of roughly 46% makes it the single most reported adverse event in retatrutide clinical trials 2026 data
If there is a lighter, there is work
Label information also notes storage at controlled room temperature and protection from light
Preliminary investigation has revealed quenching of fluorescence of reaction product by MBB at high concentrations
The largest human trial had only 16 test subjects, which means that if BPC-157 had, say, a 1% risk of a truly catastrophic side effect, a test like that would have a very small chance of catching it